105 related articles for article (PubMed ID: 22503892)
1. Proton MR spectroscopy of central neurocytoma using short and long echo time: new proofs for the existence of glycine and glutamate.
Liu M; Yue Q; Isobe T; Matsumura A; Li J; Yang Z; Quan H; Xing H; Gong Q
Acad Radiol; 2012 Jul; 19(7):779-84. PubMed ID: 22503892
[TBL] [Abstract][Full Text] [Related]
2. Central neurocytoma: typical magnetic resonance spectroscopy findings and atypical ventricular dissemination.
Yeh IB; Xu M; Ng WH; Ye J; Yang D; Lim CC
Magn Reson Imaging; 2008 Jan; 26(1):59-64. PubMed ID: 17574365
[TBL] [Abstract][Full Text] [Related]
3. 3-T proton magnetic resonance spectroscopy of central neurocytoma: 3 case reports and review of the literature.
Chuang MT; Lin WC; Tsai HY; Liu GC; Hu SW; Chiang IC
J Comput Assist Tomogr; 2005; 29(5):683-8. PubMed ID: 16163043
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro MR spectroscopic profile of central neurocytomas.
Jayasundar R; Shah T; Vaishya S; Singh VP; Sarkar C
J Magn Reson Imaging; 2003 Feb; 17(2):256-60. PubMed ID: 12541233
[TBL] [Abstract][Full Text] [Related]
5. Automated MR spectroscopy of intra- and extraventricular neurocytomas.
Ueda F; Suzuki M; Matsui O; Uchiyama N
Magn Reson Med Sci; 2007; 6(2):75-81. PubMed ID: 17690537
[TBL] [Abstract][Full Text] [Related]
6. MRS characterization of central neurocytomas using glycine.
Shah T; Jayasundar R; Singh VP; Sarkar C
NMR Biomed; 2011 Dec; 24(10):1408-13. PubMed ID: 21465595
[TBL] [Abstract][Full Text] [Related]
7. In vivo proton magnetic resonance spectroscopy of central neurocytomas.
Kim DG; Choe WJ; Chang KH; Song IC; Han MH; Jung HW; Cho BK
Neurosurgery; 2000 Feb; 46(2):329-33; discussion 333-4. PubMed ID: 10690721
[TBL] [Abstract][Full Text] [Related]
8. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
[TBL] [Abstract][Full Text] [Related]
9. Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy.
Gruber S; Pinker K; Riederer F; Chmelík M; Stadlbauer A; Bittsanský M; Mlynárik V; Frey R; Serles W; Bodamer O; Moser E
Eur J Radiol; 2008 Nov; 68(2):320-7. PubMed ID: 17964104
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of SCA2 from MSA-C using proton magnetic resonance spectroscopic imaging.
Boesch SM; Wolf C; Seppi K; Felber S; Wenning GK; Schocke M
J Magn Reson Imaging; 2007 Mar; 25(3):564-9. PubMed ID: 17326083
[TBL] [Abstract][Full Text] [Related]
11. In vivo MRS study of intraventricular tumors.
Shah T; Jayasundar R; Singh VP; Sarkar C
J Magn Reson Imaging; 2011 Nov; 34(5):1053-9. PubMed ID: 22002756
[TBL] [Abstract][Full Text] [Related]
12. Reduced posterior cingulate glutamate measured by magnetic resonance spectroscopy in hyperthyroidism.
Liu X; Bai Z; Liu F; Li M; Zhang Q; Song G; Xu J
Neuro Endocrinol Lett; 2012; 33(6):626-30. PubMed ID: 23160232
[TBL] [Abstract][Full Text] [Related]
13. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.
Verma A; Saraswat VA; Radha Krishna Y; Nath K; Thomas MA; Gupta RK
Liver Int; 2008 Sep; 28(8):1095-103. PubMed ID: 18266634
[TBL] [Abstract][Full Text] [Related]
14. Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy.
Cianfoni A; Niku S; Imbesi SG
AJNR Am J Neuroradiol; 2007 Feb; 28(2):272-7. PubMed ID: 17296993
[TBL] [Abstract][Full Text] [Related]
15. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
Saini J; Chatterjee S; Thomas B; Kesavadas C
Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
[TBL] [Abstract][Full Text] [Related]
16. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
Meyerhoff DJ; MacKay S; Constans JM; Norman D; Van Dyke C; Fein G; Weiner MW
Ann Neurol; 1994 Jul; 36(1):40-7. PubMed ID: 8024260
[TBL] [Abstract][Full Text] [Related]
17. MR Spectroscopy to Distinguish between Supratentorial Intraventricular Subependymoma and Central Neurocytoma.
Ueda F; Aburano H; Ryu Y; Yoshie Y; Nakada M; Hayashi Y; Matsui O; Gabata T
Magn Reson Med Sci; 2017 Jul; 16(3):223-230. PubMed ID: 27941295
[TBL] [Abstract][Full Text] [Related]
18. Neurochemical changes in welders revealed by proton magnetic resonance spectroscopy.
Chang Y; Woo ST; Lee JJ; Song HJ; Lee HJ; Yoo DS; Kim SH; Lee H; Kwon YJ; Ahn HJ; Ahn JH; Park SJ; Weon YC; Chung IS; Jeong KS; Kim Y
Neurotoxicology; 2009 Nov; 30(6):950-7. PubMed ID: 19631686
[TBL] [Abstract][Full Text] [Related]
19. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
[TBL] [Abstract][Full Text] [Related]
20. Quantitative multivoxel proton spectroscopy of the brain in developmental delay.
Verbruggen KT; Maurits NM; Meiners LC; Brouwer OF; van Spronsen FJ; Sijens PE
J Magn Reson Imaging; 2009 Oct; 30(4):716-21. PubMed ID: 19787717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
